These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 17096460

  • 21. Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study.
    Cookson J, Keck PE, Ketter TA, Macfadden W.
    Int Clin Psychopharmacol; 2007 Mar; 22(2):93-100. PubMed ID: 17293709
    [Abstract] [Full Text] [Related]

  • 22. Treatments for late-life bipolar disorder.
    Aziz R, Lorberg B, Tampi RR.
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [Abstract] [Full Text] [Related]

  • 23. Quetiapine-induced obsessive-compulsive symptoms: a series of five cases.
    Stamouli S, Lykouras L.
    J Clin Psychopharmacol; 2006 Aug; 26(4):396-400. PubMed ID: 16855458
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
    Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W, BOLDER Study Group.
    Bipolar Disord; 2007 Jun; 9(4):413-25. PubMed ID: 17547587
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Efficacy of quetiapine monotherapy in rapid-cycling bipolar disorder in comparison with sodium valproate.
    Langosch JM, Drieling T, Biedermann NC, Born C, Sasse J, Bauer H, Walden J, Bauer M, Grunze H.
    J Clin Psychopharmacol; 2008 Oct; 28(5):555-60. PubMed ID: 18794653
    [Abstract] [Full Text] [Related]

  • 35. Manic symptoms probably associated with short-term low-dose quetiapine use.
    Erberk-Ozen N.
    Adv Ther; 2008 Jan; 25(1):53-8. PubMed ID: 18224291
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).
    Thase ME, Macfadden W, Weisler RH, Chang W, Paulsson B, Khan A, Calabrese JR, BOLDER II Study Group.
    J Clin Psychopharmacol; 2006 Dec; 26(6):600-9. PubMed ID: 17110817
    [Abstract] [Full Text] [Related]

  • 37. [Quetiapine in substance use disorders, abuse and dependence possibility: a review].
    Erdoğan S.
    Turk Psikiyatri Derg; 2010 Dec; 21(2):167-75. PubMed ID: 20514567
    [Abstract] [Full Text] [Related]

  • 38. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B, Vanelli M, Hyde J, Perez R, Ahokpossi C, Sribney W, Adkison L.
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [Abstract] [Full Text] [Related]

  • 39. Quetiapine-induced leucopenia and thrombocytopenia.
    Shankar BR.
    Psychosomatics; 2007 Sep; 48(6):530-1. PubMed ID: 18071101
    [Abstract] [Full Text] [Related]

  • 40. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C, Lerner V.
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.